Literature DB >> 2426579

Gene expression from both intronless and intron-containing Rous sarcoma virus clones is specifically inhibited by anti-sense RNA.

L J Chang, C M Stoltzfus.   

Abstract

To distinguish the inhibitory effect of anti-sense RNA on translation from the effect on splicing, a plasmid (pLC32) was constructed from a cDNA clone of the Rous sarcoma virus (RSV) envelope gene (env) mRNA. Transcription of this plasmid results in the synthesis of RNA identical to the RSV env gene mRNA which does not require splicing to be expressed. Plasmids derived from pLC32 were also constructed in which the env gene coding sequence and 5' noncoding leader sequences were inserted in the opposite orientation relative to the RSV long terminal repeats (LTRs). pLC32 DNA transfected by the calcium phosphate coprecipitation technique efficiently rescued infectious virus from quail cells infected with an RSV mutant deleted in the env gene [R(-)Q cells], indicating that the intron sequences are dispensable in env gene expression. When the inverted constructs were cotransfected with pLC32, significantly less infectious virus was produced. The extent of the inhibition depended upon the concentration ratio of the two plasmids. The maximum inhibition (80%) occurred when the ratio of inverted constructs to pLC32 was 12:1. The inhibition is specific for the inverted orientation since cotransfection of pLC32 with several other plasmids containing viral LTRs and defective src and env genes at similar concentrations did not inhibit the production of infectious virus. In addition, the inverted constructs did not interfere with the expression of an LTR-driven chloramphenicol acetyltransferase gene. When cotransfected with a wild-type Prague A RSV DNA plasmid (pJD100), the inverted constructs also greatly inhibited expression and replication of virus in R(-)Q quail cells. These data suggest that the specific inhibition is caused by hybridization of complementary RNA transcribed from the inverted constructs to the env mRNA, thereby blocking its expression. The fact that expression of both intron-containing and intronless clones are inhibited to the same extent suggest that inhibition by anti-sense RNA from the env exon regions does not act at the level of RNA splicing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2426579      PMCID: PMC366961          DOI: 10.1128/mcb.5.9.2341-2348.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  ANALYSIS OF THE DEFECTIVENESS OF ROUS SARCOMA VIRUS, II. SPECIFICATION OF RSV ANTIGENICITY BY HELPER VIRUS.

Authors:  H HANAFUSA; T HANAFUSA; H RUBIN
Journal:  Proc Natl Acad Sci U S A       Date:  1964-01       Impact factor: 11.205

2.  Splicing and the formation of stable RNA.

Authors:  D H Hamer; P Leder
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

3.  Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation.

Authors:  B M Paterson; B E Roberts; E L Kuff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

4.  Temperature-sensitive avian sarcoma viruses: a physiological comparison of twenty mutants.

Authors:  J A Wyke; M Linial
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

5.  Structure-function relationship of Rous sarcoma virus leader RNA.

Authors:  J L Darlix; M Zuker; P F Spahr
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

6.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus.

Authors:  R Swanstrom; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

8.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

9.  Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.

Authors:  M L Stephenson; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

10.  Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40.

Authors:  P Gruss; C J Lai; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

View more
  14 in total

1.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation.

Authors:  T Akagi; T Shishido; K Murata; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism.

Authors:  N R Landau; D R Littman
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Inhibition of SV40 gene expression by microinjected small antisense RNA and DNA molecules.

Authors:  M Graessmann; G Michaels; B Berg; A Graessmann
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

4.  Inhibition of Rous sarcoma virus replication by antisense RNA.

Authors:  L J Chang; C M Stoltzfus
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Inhibition of retroviral replication by anti-sense RNA.

Authors:  R Y To; S C Booth; P E Neiman
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Antisense RNA inhibits endogenous gene expression in mouse preimplantation embryos: lack of double-stranded RNA "melting" activity.

Authors:  A Bevilacqua; R P Erickson; V Hieber
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA.

Authors:  T von Rüden; E Gilboa
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Introns are inconsequential to efficient formation of cellular thymidine kinase mRNA in mouse L cells.

Authors:  M K Gross; M S Kainz; G F Merrill
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

9.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication.

Authors:  B A Sullenger; T C Lee; C A Smith; G E Ungers; E Gilboa
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

10.  Specific gene suppression by engineered ribozymes in monkey cells.

Authors:  F H Cameron; P A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.